2 mins to read
Molten Ventures is pleased to announce our lead investment in PolyModels Hub £7m Series A, alongside Marathon Venture Capital, to help accelerate the digital transformation of biopharma process development. This investment marks a meaningful step forward in how new medicines reach patients, and we’re proud to support a team that’s reimagining the future of drug development.
PolyModels Hub is changing the way pharmaceutical companies develop and manufacture medicines. Their platform, built by experts for pharma teams, brings advanced modelling, simulation, and workflow management together in one intuitive digital hub. With PolyModels Hub, scientists and engineers can design, test, and improve drug development processes faster and more efficiently - helping companies save time, reduce costs, and deliver better medicines.
Already trusted by four of the world’s top ten pharmaceutical companies, Polymodels Hub has quickly established itself as a critical enabler of modern drug development. Its technology is delivering measurable results, with the potential to save hundreds of millions of pounds per drug by streamlining and accelerating process development.
We believe PolyModels Hub has come along at exactly the right moment for the industry. As clinical trials and patient recruitment move faster, drug development teams need better ways to keep pace. PolyModels Hub makes it easier for these teams to design and refine how medicines are made, helping them
What’s impressed us most is the PolyModels Hub team’s blend of technical know-how and deep understanding of their customers’ real-world challenges. They’ve built a solution that delivers value in weeks, not years, and their rapid adoption by major pharma companies speaks volumes. The feedback is clear: PolyModels Hub is quickly becoming a must-have for anyone serious about bringing new medicines to market.
This investment will help PolyModels Hub expand their engineering and product teams, enhance their core platform, and reach more pharma companies worldwide. The team will focus on building scalable solutions for process and regulatory workflows, making it even easier for customers to adopt and benefit from their technology.
By doubling down on product excellence and supporting the most impactful use cases, PolyModels Hub aims to become the go-to digital backbone for process development across the industry.
"PolyModels Hub is solving a real pain point for pharma teams, bringing together deep domain expertise and cutting-edge technology in a way that’s genuinely transformative. We’re proud to support Antonio B, Antonio Y, Harry and the team as they scale their impact across the industry."
“The pharmaceutical industry is undergoing a once-in-a-generation digital transformation. In just 18 months, our technology and exceptional team have delivered tangible value to major pharma partners across multiple blockbuster programs, expanding these collaborations to a truly global scale. I’m incredibly excited about the road ahead — and about welcoming Molten Ventures as a partner on this journey. We’re investing deeply in complex biologics and advancing our platform to empower scientists with the model-based solutions they deserve to transform molecules into medicines for the 21st century.”
